Research Facts & Compound Information
This page provides general scientific background on selected research compounds and peptide-related pathways. This information is provided for educational and laboratory research context only. Nothing on this page is medical advice, dosing guidance, human-use instruction, or a recommendation for consumption.
For Research Use Only. Not for human or veterinary consumption. Not a drug, food, dietary supplement, or cosmetic. Not intended to diagnose, treat, cure, or prevent any disease.
GLP-1 Research
GLP-1 stands for glucagon-like peptide-1. GLP-1 receptor agonists are studied for their role in glucose-dependent insulin signaling, glucagon regulation, gastric emptying pathways, appetite-related signaling, and metabolic research. Semaglutide is a GLP-1 receptor agonist studied in metabolic and endocrine research models.
- GLP-1 receptors are involved in glucose and insulin signaling pathways.
- GLP-1 receptor activation is studied in metabolic, endocrine, and pharmacology research.
- Semaglutide is a GLP-1 receptor agonist.
- Research-use semaglutide sold on this website is not medicine and is not for human or animal use.
GIP Research
GIP stands for glucose-dependent insulinotropic polypeptide. GIP receptor activity is studied for its relationship to insulin secretion, nutrient response, and energy metabolism. Tirzepatide is a dual GIP and GLP-1 receptor agonist.
- GIP is an incretin hormone involved in metabolic signaling.
- GIP receptor research often overlaps with GLP-1 pathway research.
- Tirzepatide activates both GIP and GLP-1 receptor pathways in research settings.
- Research-use tirzepatide is not a consumer medication.
Glucagon Receptor Research
The glucagon receptor is studied for its role in hepatic glucose output, energy expenditure, lipid metabolism, and broader metabolic regulation. Retatrutide is an investigational triple receptor agonist associated with GIP, GLP-1, and glucagon receptor research.
- Glucagon receptor pathways are involved in glucose and energy regulation.
- Retatrutide is investigational.
- Retatrutide is studied as a triple receptor agonist: GIP, GLP-1, and glucagon.
- Retatrutide products on this website are research materials only.
PDE5 Research
PDE5 stands for phosphodiesterase type 5. PDE5 inhibitors are studied for their role in cyclic GMP signaling pathways. Sildenafil and tadalafil are PDE5 inhibitor reference materials used in biochemical and analytical research contexts.
- PDE5 breaks down cyclic GMP.
- PDE5 inhibitors are studied in nitric oxide and cGMP signaling research.
- Sildenafil and tadalafil are PDE5 inhibitor reference materials.
- Research materials are not intended for treatment, diagnosis, or consumption.
Product Fact Table
- Compound type
- PDE5 inhibitor reference material
- Primary pathway
- PDE5 / cyclic GMP signaling
- Research category
- Biochemical and analytical research
- Form
- Research material
- Intended use
- Laboratory research only
- Human or veterinary use
- Not permitted
- Compound type
- PDE5 inhibitor reference material
- Primary pathway
- PDE5 / cyclic GMP signaling
- Research category
- Biochemical and analytical research
- Form
- Research material
- Intended use
- Laboratory research only
- Human or veterinary use
- Not permitted
- Compound type
- Peptide research material
- Primary pathway
- GLP-1 receptor
- Research category
- Metabolic and endocrine research
- Form
- Lyophilized
- Intended use
- Laboratory research only
- Human or veterinary use
- Not permitted
- Compound type
- Peptide research material
- Primary pathway
- GIP and GLP-1 receptors
- Research category
- Incretin and metabolic research
- Form
- Lyophilized
- Intended use
- Laboratory research only
- Human or veterinary use
- Not permitted
- Compound type
- Investigational research peptide
- Primary pathway
- GIP, GLP-1, and glucagon receptors
- Research category
- Metabolic and endocrine research
- Form
- Lyophilized
- Research status
- Investigational
- Intended use
- Laboratory research only
- Human or veterinary use
- Not permitted